KEGG: cel:CELE_C52E12.2
STRING: 6239.C52E12.2b
Here’s a structured collection of FAQs tailored for academic researchers working with the UNC-104 antibody, incorporating experimental design, data interpretation, and methodological insights from peer-reviewed studies:
Methodological Answer:
Primary Validation: Use genetic controls (e.g., unc-104 null mutants) to confirm antibody specificity. For example, compare protein levels in wild-type vs. unc-104(e1265) mutants, which exhibit reduced motor levels due to cargo-binding defects .
Secondary Validation: Perform immunostaining with tagged UNC-104 rescue constructs (e.g., mCherry-UNC-104) to confirm colocalization .
Key Data:
| Sample | UNC-104 Signal Intensity (Western Blot) |
|---|---|
| WT | High |
| unc-104(e1265) | Low (≈20% of WT) |
| Rescue (WT cDNA) | Restored signal |
Methodological Answer:
Model Organisms:
Key Parameters: Quantify NMJ length, bouton size, and PSD density in mutants vs. controls .
Methodological Answer:
Scenario: Discrepancies between Western blot (low UNC-104 levels) and FRAP (unchanged diffusivity) data.
Approach:
Key Finding: Ubiquitination alters cargo binding but not transport dynamics, explaining preserved motor distribution despite reduced protein levels .
Methodological Answer:
Live Imaging: Track mCherry-UNC-104 vesicles in Drosophila larvae using spinning-disk confocal microscopy .
Electron Microscopy: Measure active zone (AZ) and postsynaptic density (PSD) apposition in unc-104 mutants .
Key Data:
| Genotype | AZ-PSD Apposition (%) | Bouton Size (μm²) |
|---|---|---|
| WT | 95 ± 3 | 12.5 ± 1.2 |
| unc-104<sup>bris</sup> | 42 ± 7 | 8.3 ± 0.9 |
| Rescue | 78 ± 5 | 10.8 ± 1.1 |
Methodological Answer:
Ubiquitination Impact: Use proteasome inhibitors (e.g., MG-132) to block degradation and assess UNC-104 accumulation in synaptic regions .
Antibody Selection: Opt for antibodies targeting non-PTM domains (e.g., PH domain vs. FHA domain) to avoid epitope masking.
Key Finding: The D1497N mutation in the PH domain reduces cargo binding but does not disrupt antibody recognition of linear epitopes .
Methodological Answer:
Kinetic Modeling: Use a Master equation for cargo binding and a Fokker-Planck equation for motor density dynamics .
Parameters: Include processivity (≈1.2 μm/s), diffusivity (≈0.05 μm²/s), and cooperative binding coefficients .
Methodological Answer:
Methodological Answer: